Kinase Inhibitors and Ovarian Cancer

Ovarian cancer is fifth in the rankings of cancer deaths among women, and accounts for more deaths than any other gynecological malignancy. Despite some improvement in overall-(OS) and progression-free survival (PFS) following surgery and first-line chemotherapy, there is a need for development of n...

Descripción completa

Detalles Bibliográficos
Autores principales: Katopodis, Periklis, Chudasama, Dimple, Wander, Gurleen, Sales, Louise, Kumar, Juhi, Pandhal, Manreen, Anikin, Vladimir, Chatterjee, Jayanta, Hall, Marcia, Karteris, Emmanouil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770231/
https://www.ncbi.nlm.nih.gov/pubmed/31547471
http://dx.doi.org/10.3390/cancers11091357

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770231/
https://www.ncbi.nlm.nih.gov/pubmed/31547471
http://dx.doi.org/10.3390/cancers11091357

Ejemplares similares